Trials / Withdrawn
WithdrawnNCT03306966
Assessing the Safety and Performance of the Endoscopic Linear Cutter Stapler and Reloads (Frankenman) in Colectomy
Assessing the Safety and Performance of the Single Use Endoscopic Linear Cutter Stapler and Reloads (Frankenman) in Colectomy: a Monocentric Post-market Observational Study
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Duomed · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this observational study is to evaluate the safety and performance of the Single Use Endoscopic Linear Cutter Stapler and Reloads from Frankenman used in (hemi)colectomy to remove tumors and create anastomoses in patients with cancer in the ascending colon. The goal of the study will be achieved by assessing the device performance and reporting of peri- and postoperative complications in a prospectively maintained database.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Endoscopic Linear Cutter Stapler and Reloads (Frankenman) | The Single Use Endoscopic Linear Cutter Stapler and Reloads from Frankenman received CE-mark in April 2013. It is used to staple and simultaneously divide tissue from the central line. |
Timeline
- Start date
- 2018-05-01
- Primary completion
- 2020-05-01
- Completion
- 2021-01-30
- First posted
- 2017-10-11
- Last updated
- 2018-06-01
Source: ClinicalTrials.gov record NCT03306966. Inclusion in this directory is not an endorsement.